| Pathways between childhood trauma, intimate partner violence, and harsh parenting: findings from the UN Multi-country Study on Men and Violence in Asia and the Pacific E Fulu, S Miedema, T Roselli, S McCook, KL Chan, R Haardörfer, ... The Lancet Global Health 5 (5), e512-e522, 2017 | 230 | 2017 |
| Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies BA McGregor, MT Campbell, W Xie, S Farah, MA Bilen, AL Schmidt, ... Cancer 127 (6), 840-849, 2021 | 66 | 2021 |
| Clinical activity and safety of cabozantinib for brain metastases in patients with renal cell carcinoma L Hirsch, NM Chanza, S Farah, W Xie, R Flippot, DA Braun, N Rathi, ... JAMA oncology 7 (12), 1815-1823, 2021 | 50 | 2021 |
| Do lung cancer eligibility criteria align with risk among Blacks and Hispanics? K Fiscella, P Winters, S Farah, M Sanders, SG Mohile PLoS One 10 (11), e0143789, 2015 | 41 | 2015 |
| UN Multi-country Study on Men and Violence Study Team (2017) Pathways between childhood trauma, intimate partner violence, and harsh parenting: Findings from the UN multi … E Fulu, S Miedema, T Roselli, S McCook, KL Chan, R Haardörfer, ... The Lancet Global Health 5 (5), e512-e522, 2017 | 27 | 2017 |
| “Get Ready and Empowered About Treatment”(GREAT) study: a pragmatic randomized controlled trial of activation in persons living with HIV JK Carroll, JN Tobin, A Luque, S Farah, M Sanders, A Cassells, SM Fine, ... Journal of general internal medicine 34, 1782-1789, 2019 | 26 | 2019 |
| Men’s attitude and practices regarding gender and violence against women in Bangladesh: Preliminary findings RT Naved, H Huque, S Farah, MMR Shuvra Print Link Printers, 2011 | 22 | 2011 |
| Assessment of immune checkpoint inhibitors and genomic alterations by body mass index in advanced renal cell carcinoma AKA Lalani, Z Bakouny, S Farah, F Donskov, S Dudani, DYC Heng, ... JAMA oncology 7 (5), 773-775, 2021 | 21 | 2021 |
| Addressing medication costs during primary care visits: a before–after study of team-based training JK Carroll, S Farah, RJ Fortuna, AM Lanigan, M Sanders, JV Venci, ... Annals of Internal Medicine 170 (9_Supplement), S46-S53, 2019 | 21 | 2019 |
| Activation of persons living with HIV for treatment, the great study K Fiscella, M Boyd, J Brown, J Carroll, A Cassells, R Corales, W Cross, ... BMC Public Health 15, 1-9, 2015 | 21 | 2015 |
| Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/PREPEC): a pragmatic, multicentre … EA Kappos, A Schulz, MM Regan, G Moffa, Y Harder, K Ribi, S Potter, ... BMJ open 11 (9), e045239, 2021 | 20 | 2021 |
| Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy G Jerusalem, S Farah, A Courtois, J Chirgwin, S Aebi, P Karlsson, ... Annals of oncology 32 (10), 1256-1266, 2021 | 19 | 2021 |
| Drug-and alcohol-associated deaths in US Jails K Fiscella, M Noonan, SH Leonard, S Farah, M Sanders, SE Wakeman, ... Journal of Correctional Health Care 26 (2), 183-193, 2020 | 18 | 2020 |
| Utility of normalized body composition areas, derived from outpatient abdominal CT using a fully automated deep learning method, for predicting subsequent cardiovascular events K Magudia, CP Bridge, CP Bay, S Farah, A Babic, FJ Fintelmann, LK Brais, ... American Journal of Roentgenology 220 (2), 236-244, 2023 | 13 | 2023 |
| Biomarkers of angiogenesis and clinical outcomes to cabozantinib and everolimus in patients with metastatic renal cell carcinoma from the phase III METEOR trial T Denize, S Farah, A Cimadamore, A Flaifel, E Walton, MA Sticco-Ivins, ... Clinical Cancer Research 28 (4), 748-755, 2022 | 13 | 2022 |
| Phase II study of nivolumab and ipilimumab for advanced rare genitourinary cancers. BA McGregor, MT Campbell, W Xie, S Farah, MA Bilen, G Sonpavde, ... Journal of Clinical Oncology 38 (15_suppl), 5018-5018, 2020 | 13 | 2020 |
| Activity and safety of cabozantinib (cabo) in brain metastases (BM) from metastatic renal cell carcinoma (mRCC): An international multicenter study. L Hirsch, N Martinez Chanza, S Farah, R Flippot, N Rathi, K Collier, ... Journal of clinical oncology 39 (6_suppl), 310-310, 2021 | 9 | 2021 |
| Improving patient-centered communication while using an electronic health record: Report from a curriculum evaluation CT Fogarty, P Winters, S Farah The International Journal of Psychiatry in Medicine 51 (4), 379-389, 2016 | 8 | 2016 |
| Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor–Positive, ERBB2-Negative … E Munzone, MM Regan, S Cinieri, E Montagna, L Orlando, R Shi, ... JAMA oncology 9 (9), 1267-1272, 2023 | 6 | 2023 |
| Biomarker-based phase II study of sapanisertib (TAK-228): an mTORC1/2 inhibitor in patients with refractory metastatic renal cell carcinoma BA McGregor, W Xie, E Adib, WM Stadler, Y Zakharia, A Alva, ... JCO precision oncology 6, e2100448, 2022 | 6 | 2022 |
Kevin FiscellaUniversity of Rochester Medical CenterVerifierad e-postadress på urmc.rochester.edu
